Story perspectives

Robotic Surgery Revolution: New Platforms and Major Investments

10/7/2025

40 9

Summary

Story summary

Ronovo launched the Carina platform for laparoscopic surgery in February 2023; National Medical Products Administration (NMPA) approved it in March 2025.
Intuitive Surgical remains the market leader; Johnson & Johnson and Medtronic are expanding their programs.
Medtronic submitted Hugo to the U.S. Food and Drug Administration (FDA) for urologic use, aiming for early 2025.
Capstan Medical performed the first robot-assisted transcatheter mitral valve replacements in March 2025 in Chile.
Olympus announced a $458 million investment in a new endoluminal robotic system for gastrointestinal care.

1 of 1

Story summary

Ronovo launched the Carina platform for laparoscopic surgery in February 2023; National Medical Products Administration (NMPA) approved it in March 2025.
Intuitive Surgical remains the market leader; Johnson & Johnson and Medtronic are expanding their programs.
Medtronic submitted Hugo to the U.S. Food and Drug Administration (FDA) for urologic use, aiming for early 2025.
Capstan Medical performed the first robot-assisted transcatheter mitral valve replacements in March 2025 in Chile.
Olympus announced a $458 million investment in a new endoluminal robotic system for gastrointestinal care.